Noah Rosenberg Net Worth & Insider Trades
Noah Rosenberg - Chief Medical Officer, Retrophin, Inc
What is Noah Rosenberg's Net Worth?
The current estimated net worth of Retrophin, Inc's Chief Medical Officer, Noah Rosenberg, is estimated to be about $366.78K . Noah Rosenberg owns about 27,555 units of Retrophin, Inc common stock. In the last 2 years at Retrophin, Inc, Noah Rosenberg has sold an estimated value of $131.93K worth.
What is Noah Rosenberg's Past Insider Trading?
Noah Rosenberg's largest sale order was 2,500 units , worth over $49.86K on July 31, 2019. In total, Noah Rosenberg has made about 9 transactions over 2 years of their time at Retrophin, Inc. Noah Rosenberg usually trades in July, with the busiest year in 2020. The most recent transaction was a sale order of 750 units , worth over $13.86K on September 23, 2020.
Noah Rosenberg
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Noah Rosenberg's' Mailing Address?
- Mailing address is C/o Esperion Therapeutics, Inc. 46701 Commerce Center Drive Plymouth MI 48170 MI
What are Retrophin, Inc's Past Insider Trades?
Retrophin, Inc's most recent insider trade came on November 25, 2020 by Laura Clague who sold 7,500 units worth $174.68K . In the last 8 years, insiders at Retrophin, Inc have sold an estimated value of $24.69M and bought an estimated value of $8.79M worth of shares. Insider trading is most common in May, with the busiest year in 2020. The most active traders at the company are Martin Shkreli, Steve Aselage, Director, and Laura Clague, Chief Financial Officer .
Travere Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||